Clinical management and outcomes of papillary, follicular and medullary thyroid cancer surgery

Medicinski Glasnik

Volumn 10, Issue 1, 2013, Pages 164-167

  Rahmani, Nasrin ^a   Hashemi, Seyyed Abbas ^a   Fazli, Mehran ^a   Raisian, Mohammad ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Malignancy; Survival; Thyroid; Treatment

Indexed keywords

ADULT; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; NOTE; OVERALL SURVIVAL; SUBTOTAL THYROIDECTOMY; SURVIVAL; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; ADENOCARCINOMA, FOLLICULAR; CARCINOMA, NEUROENDOCRINE; CARCINOMA, PAPILLARY, FOLLICULAR; INCIDENCE; IRAN; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; THYROID NEOPLASMS;

ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOMA, NEUROENDOCRINE; CARCINOMA, PAPILLARY, FOLLICULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84873842624     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Note

References (24)

1. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N, Zhang Y. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Cause Cont 2009; 20:525-31.
2. Bleyer, A, O'Leary M, Barr R, Ries LAG (Eds.). Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. NIH (Pub. No. 06-5767). Bethesda: National Cancer Institute, (2006). http:// seer.cancer.gov (March 13 2009)
3. Yu GP, Li JC, Branovan D, McCormick S, Schantz SP. Thyroid cancer incidence and survival in the National Cancer Institute Surveillance, Epidemiology, and End Results Race/Ethnicity Groups. Thyroid 2010; 20:465-73.
4. Mitchell I, Livingston EH, Chang AY, Holt S, Snyder WH 3rd, Lingvay I, Nwariaku FE. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery 2007; 142: 823-8.
5. Colonna M, Guizard AV, Schvartz C, Velten M, Raverdy N, Molinie F, Delafosse P, Franc B, Grosclaude P. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). Euro J Cancer 2007; 43:891-900.
6. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295:2164-7.
7. Kent WDT, Hall SF, Isotalo PA Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. Can Med Assoc J 2007; 177:1357-61.
8. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemio Biomark Prevent 2009; 18:784-91.
9. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009; 115: 3801-3807.
10. Burgess JR, Dwyer T, McArdle K, Tucker P, Shugg D. The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine suficiency to iodine deiciency. J Clin Endocr Metab 2000; 85:1513-7.
11. Mulla ZD, Margo CE. Primary malignancies of the thyroid: epidemiologic analysis of the Florida Cancer Data System registry. Ann Epidemiol 2000; 10:24-30.
12. Weissferdt A, Moran CA. Anaplastic thymic carcinoma: a clinicopathologic and immunohistochemical study of 6 cases. Hum Path 2012; 43:874-7.
13. Elliot Sampson, James D. Brierley, Lisa WL, Lorne R, Richard W. Tsang. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 2007; 110:1451-6.
14. Shaha AR, Shah JP, Loree TR. Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg 1997; 174:474-6.
15. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocr Metab1988; 67:501-8.
16. Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP, Fragu P, Lumbroso J, Caillou B, Parmentier C. Longterm results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocr Metab 1986; 63:960-7.
17. Samaan NA, Schultz PN, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocr Metab 1985; 60:376-80.
18. Brierley J, Tsang R, Panzarella T, Bana N. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 2005; 63:418-27.
19. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114:1050-7.
20. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med1994; 97:418-28.
21. Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf) 2005; 63:87-93.
22. Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocr Metab 1995; 80:2041-5.
23. Al-Zaher N, Al-Salam S, El Teraii H. Thyroid carcinoma in the United Arab Emirates: perspectives and experience of a tertiary care hospital. Hematol Oncol Stem Cell Ther 2008; 1:14-21.
24. Bukhari U, Sadiq S, Memon J, Baig F. Thyroid carcinoma in Pakistan: a retrospective review of 998 cases from an academic referral center. Hematol Oncol Stem Cell Ther 2009; 2:345-8.